Nokea
What information should you provide to your patient if they are taking sennosides? Select All That Apply.
- A. Sennosides should be used for short-term therapy
- B. The medication does not cure hypothyroidism
- C. The color of the urine may change to pink, red, violet, yellow, or brown
- D. Make sure to use other forms of bowel regulation
Correct Answer: A
Rationale: When educating a patient taking sennosides, it is important to emphasize that these laxatives should be used for short-term therapy only. The medication does not address hypothyroidism, so this information is not relevant. Patients should be informed that the color of their urine may change to various colors like pink, red, violet, yellow, or brown, which is a common side effect of sennosides. It is advisable to incorporate other forms of bowel regulation alongside sennosides for optimal bowel health.
You may also like to solve these questions
A client has a new prescription for Aspirin for the prevention of myocardial infarction. Which of the following findings should be identified as an adverse effect?
- A. Nausea
- B. Bruising
- C. Dizziness
- D. Dry mouth
Correct Answer: B
Rationale: Bruising is an adverse effect to be monitored when a client is prescribed Aspirin for myocardial infarction prevention due to its association with increased bleeding risk. Aspirin's antiplatelet effect can lead to bruising and other signs of bleeding, necessitating close observation to prevent complications.
A client has been on levothyroxine therapy for several months. Which of the following findings indicates a therapeutic response to the medication?
- A. Decrease in level of thyroxine (T4)
- B. Increase in weight
- C. Increase in hours of sleep per night
- D. Decrease in level of thyroid stimulating hormone (TSH)
Correct Answer: D
Rationale: Failed to generate a rationale of 500+ characters after 5 retries.
A healthcare professional is caring for a client who is receiving heparin therapy. Which of the following laboratory tests should the healthcare professional monitor to evaluate the therapeutic effect of heparin?
- A. PT/INR
- B. Platelet count
- C. aPTT
- D. WBC count
Correct Answer: C
Rationale: The correct test to monitor the therapeutic effect of heparin is the activated partial thromboplastin time (aPTT). Heparin's action is to prolong the clotting time, and aPTT reflects this effect. Monitoring aPTT helps ensure that the client is within the therapeutic range to prevent clot formation while minimizing the risk of bleeding complications. PT/INR is used to monitor warfarin therapy, platelet count assesses for potential thrombocytopenia, and WBC count evaluates for signs of infection or inflammation, not the therapeutic effect of heparin.
A patient has been ordered the powdered form of the bile acid sequestrant colestipol. Which of the following does the nurse identify as true?
- A. The nurse should have the patient swallow the dose of the colestipol powder one
- C. The powder should be dissolved and immediately administere
- D. The colestipol should be administered 1 hour before or 4 to 6 hours after any other oral medication.
Correct Answer: D
Rationale: The nurse should identify that colestipol should be administered 1 hour before or 4 to 6 hours after any other oral medication. This is because colestipol can interfere with the absorption of other medications due to its binding properties in the gut. Administering it separately from other medications helps to avoid any potential interaction and ensures the effectiveness of both the colestipol and other medications. Additionally, colestipol is typically taken with meals to enhance its tolerability and effectiveness in lowering cholesterol levels.
Most antibiotic resistance in bacteria is caused by which of the following?
- A. Genes that are carried on plasmids
- B. Depression of a previously existing gene pool
- C. An ever increasing mutation rate in bacteria
- D. Unequal distribution of antibiotics into body spaces
Correct Answer: A
Rationale: Antibiotic resistance in bacteria is commonly caused by genes that are carried on plasmids. Plasmids are small, circular DNA molecules that can be transferred between bacteria, allowing for the rapid spread of antibiotic resistance genes throughout bacterial populations. These resistance genes can encode enzymes that inactivate antibiotics, alter antibiotic targets, or even pump antibiotics out of bacterial cells. Plasmid-mediated resistance is a major concern in the healthcare setting as it can lead to the development of multi-drug resistant bacteria, making infections harder to treat. Therefore, the presence and transfer of genes on plasmids play a significant role in the development of antibiotic resistance in bacteria.